» Articles » PMID: 27821595

Cannabis Exposure As an Interactive Cardiovascular Risk Factor and Accelerant of Organismal Ageing: a Longitudinal Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Nov 9
PMID 27821595
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Many reports exist of the cardiovascular toxicity of smoked cannabis but none of arterial stiffness measures or vascular age (VA). In view of its diverse toxicology, the possibility that cannabis-exposed patients may be ageing more quickly requires investigation.

Design: Cross-sectional and longitudinal, observational. Prospective.

Setting: Single primary care addiction clinic in Brisbane, Australia.

Participants: 11 cannabis-only smokers, 504 tobacco-only smokers, 114 tobacco and cannabis smokers and 534 non-smokers.

Exclusions: known cardiovascular disease or therapy or acute exposure to alcohol, amphetamine, heroin or methadone.

Intervention: Radial arterial pulse wave tonometry (AtCor, SphygmoCor, Sydney) performed opportunistically and sequentially on patients between 2006 and 2011.

Main Outcome Measure: Algorithmically calculated VA.

Secondary Outcomes: other central haemodynamic variables.

Results: Differences between group chronological ages (CA, 30.47±0.48 to 40.36±2.44, mean±SEM) were controlled with linear regression. Between-group sex differences were controlled by single-sex analysis. Mean cannabis exposure among patients was 37.67±7.16 g-years. In regression models controlling for CA, Body Mass Index (BMI), time and inhalant group, the effect of cannabis use on VA was significant in males (p=0.0156) and females (p=0.0084). The effect size in males was 11.84%. A dose-response relationship was demonstrated with lifetime exposure (p<0.002) additional to that of tobacco and opioids. In both sexes, the effect of cannabis was robust to adjustment and was unrelated to its acute effects. Significant power interactions between cannabis exposure and the square and cube of CA were demonstrated (from p<0.002).

Conclusions: Cannabis is an interactive cardiovascular risk factor (additional to tobacco and opioids), shows a prominent dose-response effect and is robust to adjustment. Cannabis use is associated with an acceleration of the cardiovascular age, which is a powerful surrogate for the organismal-biological age. This likely underlies and bi-directionally interacts with its diverse toxicological profile and is of considerable public health and regulatory importance.

Citing Articles

Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function.

Cheung C, Coates A, Baker R, Burr J J Am Heart Assoc. 2024; 13(23):e037731.

PMID: 39575727 PMC: 11681564. DOI: 10.1161/JAHA.124.037731.


Key insights into cannabis-cancer pathobiology and genotoxicity.

Reece A, Hulse G Addict Biol. 2024; 29(11):e70003.

PMID: 39538372 PMC: 11560801. DOI: 10.1111/adb.70003.


Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.

Reece A, Hulse G Front Psychiatry. 2023; 14:1182536.

PMID: 37854446 PMC: 10579598. DOI: 10.3389/fpsyt.2023.1182536.


Cannabis and Other Substance Misuse: Implications and Regulations.

Khairinisa M, Alfaqeeh M, Rafif S, Muljono F, Colin M Toxics. 2023; 11(9).

PMID: 37755766 PMC: 10534492. DOI: 10.3390/toxics11090756.


Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.

Reece A, Hulse G Front Psychiatry. 2023; 14:1182535.

PMID: 37732074 PMC: 10507876. DOI: 10.3389/fpsyt.2023.1182535.


References
1.
Steffens S, Veillard N, Arnaud C, Pelli G, Burger F, Staub C . Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature. 2005; 434(7034):782-6. DOI: 10.1038/nature03389. View

2.
Sarafian T, Habib N, Oldham M, Seeram N, Lee R, Lin L . Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol. 2006; 290(6):L1202-9. DOI: 10.1152/ajplung.00371.2005. View

3.
Murray C, Barber R, Foreman K, Abbasoglu Ozgoren A, Abd-Allah F, Abera S . Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015; 386(10009):2145-91. PMC: 4673910. DOI: 10.1016/S0140-6736(15)61340-X. View

4.
Reece A . Chronic toxicology of cannabis. Clin Toxicol (Phila). 2009; 47(6):517-24. DOI: 10.1080/15563650903074507. View

5.
Szutorisz H, Dinieri J, Sweet E, Egervari G, Michaelides M, Carter J . Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology. 2014; 39(6):1315-23. PMC: 3988557. DOI: 10.1038/npp.2013.352. View